TY - JOUR KW - Anti-Bacterial Agents KW - Dapsone KW - DNA, Bacterial KW - Drug Resistance, Bacterial KW - Genes, Bacterial KW - Humans KW - leprosy KW - Mycobacterium leprae KW - polymerase chain reaction KW - Rifampin KW - Sequence Analysis, DNA KW - United States AU - Williams DL AU - Lewis C AU - Sandoval FG AU - Robbins N AU - Keas S AU - Gillis T AU - Scollard D AB -

Molecular drug susceptibility testing was performed on 39 US patients with leprosy. Of these, 2 had dapsone-resistant Mycobacterium leprae and 1 of these patients also had rifampin-resistant M. leprae. Even though antileprosy drug resistance occurs in this leprosy population, resistance does not appear to be a major problem.

BT - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America C1 - http://www.ncbi.nlm.nih.gov/pubmed/24065328?dopt=Abstract DA - 2014 Jan DO - 10.1093/cid/cit628 IS - 1 J2 - Clin. Infect. Dis. LA - eng N2 -

Molecular drug susceptibility testing was performed on 39 US patients with leprosy. Of these, 2 had dapsone-resistant Mycobacterium leprae and 1 of these patients also had rifampin-resistant M. leprae. Even though antileprosy drug resistance occurs in this leprosy population, resistance does not appear to be a major problem.

PY - 2014 SP - 72 EP - 3 T2 - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America TI - Drug resistance in patients with leprosy in the United States. UR - https://academic.oup.com/cid/article/58/1/72/372994 VL - 58 SN - 1537-6591 ER -